Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Features

Letter from the Editor Image

Letter from the Editor

ALM Staff & Law Journal Newsletters

A "hello" from our new Editor-in-Chief, Elizabeth Anne "Betiayn" Tursi.

Quiz of the Month Image

Quiz of the Month

ALM Staff & Law Journal Newsletters

Test your knowledge of the law!

Cameo Clips Image

Cameo Clips

ALM Staff & Law Journal Newsletters

Copyright Jurisdiction/ Television Licenses The issue of whether a TV programming license was properly terminated is to be decided by a state, rather…

Quiz of the Month Image

Quiz of the Month

ALM Staff & Law Journal Newsletters

Test your knowledge of the law!

Quiz of the Month Image

Quiz of the Month

ALM Staff & Law Journal Newsletters

Test your knowledge of the law!

Features

CA Governor Signs Harshest Anti-Spam Bill in U.S. Image

CA Governor Signs Harshest Anti-Spam Bill in U.S.

Steven Salkin, Esq.

He may be voted out of office soon, but California Governor Gray Davis is making his mark in the Internet world before he goes. On September 23, Davis signed what to date is the toughest anti-spam bill in the U.S.

Features

Non-Prescription Drug Ad Restructions Eased in UK Image

Non-Prescription Drug Ad Restructions Eased in UK

ALM Staff & Law Journal Newsletters

The latest from the UK.

<i>Daubert </i>Tool Lets Lawyers Track History of Experts Image

<i>Daubert </i>Tool Lets Lawyers Track History of Experts

Robert J. Ambrogi

Expert testimony can be the linchpin that makes or breaks a case. But lawyers have had a tougher time getting that testimony admitted since 1993, when the U.S. Supreme Court decided in <i>Daubert v. Merrell Dow Pharmaceuticals</i> that scientific testimony must be not only relevant, but reliable. In 1999's <i>Kumho Tire v. Carmichael</i>, the Court extended that rule to all experts. This means that a lawyer preparing to qualify or challenge an expert at trial must answer a number of questions. What is the state of the case law under <i>Daubert</i>? How has the particular court or judge applied the rule? How have courts ruled on this type of expertise? Has this expert ever come before a judge?

Counterfeit Drugs: FDA Suggests New Counter Measures Image

Counterfeit Drugs: FDA Suggests New Counter Measures

ALM Staff & Law Journal Newsletters

<b><i>No 'Magic Bullet,' Says Task Force</i></b> The FDA's Counterfeit Drug Task Force issued its interim report on October 2. It contains potential options for a multi-pronged approach to combat counterfeit drugs. In recent years, the FDA has seen an increase in the number and sophistication of efforts to introduce counterfeit drugs. The FDA noted at the time the report was issued that the problem of counterfeit drugs is being treated separately from the problem of unapproved and potentially unsafe drugs that are being imported via the Internet and other unregulated international channels. Under current law, those drugs are purchased outside of U.S. and foreign consumer protection systems, so they are "buyer beware" products that have traveled outside of the regulatory protections of the legal U.S. drug distribution system.

Over-the-Border Drug Debate Heats to Boiling Image

Over-the-Border Drug Debate Heats to Boiling

Janice G. Inman

<b><i>The State of the Re-Importation Debate</i></b> When Gov. Rod R. Blagojevich of Illinois announced in mid-September that his state was considering buying drugs from Canada for its employees and citizens, the debate over cross-border drug purchases via the Internet and by other means, got even hotter than it was before. The pharmaceutical industry is fighting a battle similar in scope to the music industry's Internet copyright infringement war, but because no suits have been brought against 80-year-old diabetics buying insulin from pharmacies in Montreal, national debate on the issue of the purchase of foreign drugs has gotten less press of late than the debate over music piracy.

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES